Across the EU, CBD is classified as an unauthorised novel food under Regulation (EU) 2015/2283, and no Union list authorisation exists in any member state. In February 2026 EFSA set a provisional safe intake level of roughly 2 mg per day for a 70 kg adult; that is a safety opinion, not an authorisation.

Ireland applies that regime directly, with national enforcement provisions in S.I. No. 253 of 2022 and S.I. No. 747 of 2007, and no Irish derogation, public list or transitional window. Cannabidiol itself is expressly not a controlled drug in Ireland: the Food Safety Authority of Ireland states that CBD is not considered a narcotic drug and is not a controlled drug in Ireland under the Misuse of Drugs Act 1977, and the Minister for Health confirmed the same in a Dáil written answer of 2 April 2025.

What controls a CBD product in Ireland is what else is in it. A full-spectrum hemp extract contains cannabinol, which is named in the Schedule to the Misuse of Drugs Act 1977, and trace delta-9-THC, which is controlled as a cannabinol derivative at any proportion; and the State charges hemp extracts as cannabis and cannabis resin, as it did in the case decided by the High Court in July 2024. The finished product is therefore a controlled drug in Ireland notwithstanding CBD's own status.